Lamivudine during pregnancy for preventing hepatitis B virus infection in newborns

This review has been withdrawn.

The reason for withdrawal and previous versions are archived and accessible within the withdrawn record in the Cochrane Library.

Health topics:

Published:

23 November 2021

Authors:

Mumtaz K, Ahmed USyed, Zuberi NF, Salamat S, Jafri W, Shah PS

Was this helpful? Donate.

If you found this evidence helpful, please consider donating to Cochrane. We are a charity that produces accessible evidence to help people make health and care decisions.
Donate
Print
PDF
Citation
Mumtaz K, Ahmed USyed, Zuberi NF, Salamat S, Jafri W, Shah PS. Lamivudine during pregnancy for preventing hepatitis B virus infection in newborns (Protocol). Cochrane Database of Systematic Reviews 2021, Issue 11. Art. No.: CD008718. DOI: 10.1002/14651858.CD008718.pub2.